Fibrin-fibrinogen degradation products in sera of normal infants and children (Q36062704)

11 August 2017

Fibrin-fibrinogen degradation products in sera of normal infants and children (English)

1 reference

11 August 2017

W. S. Uttley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:5356984

6 May 2023

A. G. Allan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:5356984

6 May 2023

J. D. Cash

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:5356984

6 May 2023

language of work or name

English

0 references

publication date

1 December 1969

1 reference

PMC publication ID

2020358

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC2020358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:5356984

https://europepmc.org/articles/PMC2020358?pdf=render

6 May 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:5356984

https://syndication.highwire.org/content/doi/10.1136/adc.44.238.761

6 May 2023

1 reference

Crossref

DOI

10.1136/ADC.44.238.761

https://api.crossref.org/works/10.1136/ADC.44.238.761

Archives of Disease in Childhood

6 May 2023

published in

1 reference

11 August 2017

44

1 reference

11 August 2017

238

1 reference

11 August 2017

761-764

1 reference

Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2020358

Therapeutic implications of disseminated intravascular coagulation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2020358

Intravascular coagulation in fulminant meningococcemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2020358

Disseminated fibrin thromboembolism among neonates dying within 48 hours of birth

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2020358

The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2020358

Coagulation changes in the neonatal period and in early infancy.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2020358

Haemorrhage and clotting state in the newborn

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2020358

Epidemic gastroenteritis due to Escherichia coli O111 B4. II. Pathologic anatomy, with special reference of the presence of the local and generalized Shwartzman phenomena

23 September 2018

1 reference

12 December 2020

Demonstration of split products of fibrinogen in the blood of normal newborns

1 reference

12 December 2020

The biological significance of fibrinolysis

1 reference

12 December 2020

In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor

1 reference

12 December 2020

STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS

1 reference

12 December 2020

Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment

1 reference

12 December 2020

Intravascular coagulation and hyaline-membrane disease of the newborn

1 reference

12 December 2020

Split products of fibrin in the serum of newborns

1 reference

12 December 2020

Fibrin degradation products in sera of normal subjects

1 reference

12 December 2020

1 reference

12 December 2020

Clotting factors and fibrinogen split products in the extravasular space

1 reference

12 December 2020

A quick and accurate method for the determination of fibronogen in plasma

1 reference

12 December 2020

Studies on hyaline membrane disease. I. The fibrinolysin system in pathogenesis and therapy

1 reference

12 December 2020

Serum fibrin degradation products throughout normal pregnancy

1 reference

12 December 2020

Observations on the Distribution and Biological Half‐life of Human Fibrinogen

1 reference

12 December 2020

Purpura fulminans treated successfully with anticoagulation; report of a case

1 reference

12 December 2020

[Appearance of an inhibitor of thromboplastin formation during proteolysis of fibrinogen]

1 reference

12 December 2020

A new method for the determination of fibrinolytic activity by means of immunoassay of breakdown products of fibrin and fibrinogen

1 reference

12 December 2020

Blood coagulation and fibrinolysis in tissue culture and tissue repair

series ordinal

5

1 reference

Crossref

DOI

10.1136/ADC.44.238.761

https://api.crossref.org/works/10.1136/ADC.44.238.761

6 May 2023

Identifiers

DOI

10.1136/ADC.44.238.761

1 reference

11 August 2017

1 reference

PMC publication ID

2020358

11 August 2017

1 reference

PMC publication ID

2020358